Cyclosporin A inhibits the replication of diverse coronavirusesDE WILDE, Adriaan H; ZEVENHOVEN-DOBBE, Jessika C; VAN DER MEER, Yvonne et al.Journal of general virology. 2011, Vol 92, pp 2542-2548, issn 0022-1317, 7 p., 11Article

The use of cyclosporine in dermatology: Part IIRYAN, Caitriona; AMOR, Karrie T; MENTER, Alan et al.Journal of the American Academy of Dermatology. 2010, Vol 63, Num 6, pp 949-972, issn 0190-9622, 24 p.Article

The use of cyclosporine in dermatology: Part IAMOR, Karrie T; RYAN, Caitriona; MENTER, Alan et al.Journal of the American Academy of Dermatology. 2010, Vol 63, Num 6, pp 925-946, issn 0190-9622, 22 p.Article

La ciclosporine topique: Quand et comment l'utiliser ?MILAZZO, Solange; DRIMBEA, Andrei; JANY, Benjamin et al.Pratiques en ophtalmologie. 2014, Vol 8, Num 76, pp 166-169, issn 2106-9735, 4 p.Article

CiclosporinePAUL, C; GARAT, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 836-838, issn 0151-9638, 3 p.Article

Elevating bioavailability of cyclosporine A via encapsulation in artificial oil bodies stabilized by caleosinCHEN, Miles C. M; WANG, Jui-Ling; TZEN, Jason T. C et al.Biotechnology progress. 2005, Vol 21, Num 4, pp 1297-1301, issn 8756-7938, 5 p.Article

Cyclosporine for SJS/TEN: A Case Series and Review of the LiteratureREESE, Drew; HENNING, J. Scott; ROCKERS, Kyle et al.Cutis (New York, NY). 2011, Vol 87, Num 1, pp 24-29, issn 0011-4162, 6 p.Article

Cyclosporin A improves the selection of cells transfected with the puromycin acetyltransferase geneGUOPING ZHENG; LYONS, J. Guy.BioTechniques. 2002, Vol 33, Num 1, pp 32-36, issn 0736-6205, 3 p.Article

Experience with cyclosporineLANGONE, A. J; HELDERMAN, J. H.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 59-63, issn 0041-1345, 5 p., SUPArticle

Experience with cyclosporineBILLING-GRIMA, M; WOLF, P.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 285-290, issn 0041-1345, 6 p., SUPArticle

Comment un dermatologue libéral peut surveiller un traitement court du psoriasis par la ciclosporine = How will a private practice dermatologist supervise short treatment with cyclosporineSTEINER, H. G.Les Nouvelles dermatologiques. 2000, Vol 19, Num 3, pp 205-206, issn 0752-5370Conference Paper

Combination Strategy to Increase Cyclosporin A Productivity by Tolypocladium niveum Using Random Mutagenesis and Protoplast TransformationLEE, Mi-Jin; CAC THI PHUNG DUONG; HAN, Kyuboem et al.Journal of microbiology and biotechnology. 2009, Vol 19, Num 9, pp 869-872, issn 1017-7825, 4 p.Article

Sulphated polysaccharides : New insight in the prevention of cyclosporine a-induced glomerular injuryJOSEPHINE, Anthony; COOTHAN KANDASWAMY VEENA; AMUDHA, Ganapathy et al.Basic & clinical pharmacology & toxicology (Print). 2007, Vol 101, Num 1, pp 9-15, issn 1742-7835, 7 p.Article

Tetrahydrobiopterin prevents cyclosporine-induced vasomotor dysfunctionRAMZY, Danny; RAO, Vivek; TUMIATI, Laura C et al.Transplantation. 2005, Vol 79, Num 8, pp 876-881, issn 0041-1337, 6 p.Article

Experience with cyclosporineREADY, A.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 135-138, issn 0041-1345, 4 p., SUPArticle

Cyclosporine: Lessons from the first 20 yearsCORTESINI, R.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 158-162, issn 0041-1345, 5 p., SUPArticle

Nephrotoxic aspects of cyclosporineCATTANEO, D; PERICO, N; GASPARI, F et al.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 234-239, issn 0041-1345, 6 p., SUPArticle

Cyclosporine nephrotoxicity : implications for dermatologyBENNETT, W. M.International journal of dermatology. 1997, Vol 36, pp 11-14, issn 0011-9059, SUP1Conference Paper

Cyclosporine monitoringBURCKART, Gilbert J; CANAFAX, Daniel M; YEE, Gary C et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 7-8, pp 1277-1280, issn 1060-0280, 4 p.Article

From cyclosporine to the futurePONTICELLI, C; TARANTINO, A; CAMPISE, M et al.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 557S-560S, issn 0041-1345, SUPArticle

Production of fumonisins B₂ and B₄ in Tolypocladium speciesMØLGAARD MOGENSEN, Jesper; AMALIE MØLLER, Kirsten; VON FREIESLEBEN, Pernille et al.Journal of industrial microbiology & biotechnology. 2011, Vol 38, Num 9, pp 1329-1335, issn 1367-5435, 7 p.Article

Experience with cyclosporineCURTIS, J. J.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 54-58, issn 0041-1345, 5 p., SUPArticle

Potential drug interactions with cyclosporineKATZ, H. I.International journal of dermatology. 1997, Vol 36, pp 18-24, issn 0011-9059, SUP1Conference Paper

Le néoral : Un perfectionnement biopharmaceutique de la forme orale de la ciclosporine A = The neoral : A perfecting of ciclosporine AJournal de médecine de Lyon (Lyon. 1864). 1996, Num 1509, pp 177-190, issn 0021-7883Conference Proceedings

Cyclosporine A-induced changes to erythrocyte redox balance is time course-dependentLEXIS, Louise A; RICHARDS, Ross S; FASSETT, Robert G et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 97, Num 3, pp 135-140, issn 1742-7835, 6 p.Article